Colon Cancer Clinical Trials in Houston, Texas
5 studies are recruiting for colon cancer in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of SHY-ONC6 in participants with advanced or metastatic solid tumors who have progressed on or are intolerant to standard therapies. The stud…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- The University of Texas MD Anderson Cancer Center, Houston, Texas
- Locations
- 4 in total
- Run by
- SHY Therapeutics
-
PRE-ISPY Phase I/II Oncology Platform Program
PRE-ISPY Phase I/II (I-SPY-P1) is an open-label, multisite platform study with multiple ongoing drug regimen arms added by protocol amendment which is designed to evaluate single agents or combinations in locally advanced, incurable, or metastatic solid tumors and/or oligometastatic malignancy and/…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- The University of Texas MD Anderson Cancer Center, Houston, Texas
- Locations
- 10 in total
- Run by
- QuantumLeap Healthcare Collaborative
-
A Study of PHN-012 in Patients With Advanced Solid Tumors
This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of PHN-012, a novel antibody-drug conjugate (ADC), in patients with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- PHN-012-001 Site, Houston, Texas
- Locations
- 26 in total
- Run by
- Pheon Therapeutics
-
Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
The goal of this clinical research study is to learn about gastrointestinal symptoms in participants who have undergone SC or RC and their impact on the quality of life of these participants.
- Stage
- Not phased
- Ages
- 20 to 85
- Site
- MD Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- MD Anderson Cancer Center, Houston, Texas
- Locations
- 6 in total
- Run by
- ModeX Therapeutics, An OPKO Health Company
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.